Literature DB >> 10932268

Transient increase in procollagen propeptides in the CSF after subarachnoid hemorrhage.

J Sajanti1, E Heikkinen, K Majamaa.   

Abstract

BACKGROUND: Meningeal fibrosis following subarachnoid hemorrhage (SAH) has been verified histologically in experimental animals and in human autopsy samples, but the clinical course of the intrathecal fibroproliferative reaction is unknown. The authors therefore studied time-related changes in the CSF concentrations of type I (PICP) and type III (PIIINP) procollagen propeptides in patients with recent SAH.
METHOD: Fifty-two CSF samples were obtained from 39 patients with SAH treated surgically and eight samples from eight patients with SAH who were not surgically treated. The samples were analyzed for PICP and PIIINP by using radioimmunoassays.
RESULTS: The authors found a time-dependent increase in PICP and PIIINP in the CSF of the patients with SAH. Two weeks after the hemorrhage, concentrations were four times higher in patients with SAH than the concentrations in the control subjects. Concentrations in patients with SAH then declined steadily, but remained slightly but significantly elevated even at 10 weeks. PICP and PIIINP did not correlate with the age or sex of the patient or the amount of blood in the initial CT scan. Four patients developed late posthemorrhagic hydrocephalus; their PICP and PIIINP levels were higher than in matched patients with SAH without hydrocephalus.
CONCLUSIONS: Time-dependent changes in CSF concentrations of PICP and PIIINP suggest a transient fibroproliferative reaction in the meninges after SAH. The considerable magnitude and extended time course of the changes make the measurement of PICP and PIIINP practicable for the diagnosis of a fibroproliferative state in patients with recent meningeal disease. Furthermore, the results suggest a role for meningeal fibrosis in the development of late posthemorrhagic hydrocephalus.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10932268     DOI: 10.1212/wnl.55.3.359

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  7 in total

1.  Cerebrospinal fluid ferritin in chronic hydrocephalus after aneurysmal subarachnoid hemorrhage.

Authors:  Hidenori Suzuki; Masatoshi Muramatsu; Katsuhiro Tanaka; Hiroaki Fujiwara; Tadashi Kojima; Waro Taki
Journal:  J Neurol       Date:  2006-04-28       Impact factor: 4.849

2.  Delayed Medullar Syndrome after Aneurysmal Subarachnoid Haemorrhage. A Case report of Cystic Arachnoiditis!

Authors:  N Silva; A C Januel; J Sabatier; J F Demonet; P Tall; C Cognard
Journal:  Interv Neuroradiol       Date:  2007-09-13       Impact factor: 1.610

3.  Cerebrospinal fluid obstruction and malabsorption in human neonatal hydrocephaly.

Authors:  Axel Heep; Peter Bartmann; Birgit Stoffel-Wagner; Arie Bos; Eelco Hoving; Oebele Brouwer; Albert Teelken; Carlo Schaller; Deborah Sival
Journal:  Childs Nerv Syst       Date:  2006-05-13       Impact factor: 1.475

4.  Procollagen I C-propeptide in the cerebrospinal fluid of neonates with posthaemorrhagic hydrocephalus.

Authors:  A Heep; B Stoffel-Wagner; V Soditt; C Aring; P Groneck; P Bartmann
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2002-07       Impact factor: 5.747

5.  Procollagen propeptides in chronic subdural hematoma reveal sustained dural collagen synthesis after head injury.

Authors:  Anna-Leena Heula; Juha Sajanti; Kari Majamaa
Journal:  J Neurol       Date:  2009-02-09       Impact factor: 4.849

6.  Effect of cisternal drainage on the shunt dependency following aneurysmal subarachnoid hemorrhage.

Authors:  Sung Hun Kim; Pil-Wook Chung; Yu Sam Won; Young Joon Kwon; Hyun Chul Shin; Chun Sik Choi
Journal:  J Korean Neurosurg Soc       Date:  2012-11-30

7.  Syringomyelia and spinal arachnoiditis resulting from aneurysmal subarachnoid hemorrhage: Report of two cases and review of the literature.

Authors:  Taylor J Abel; Matthew A Howard; Arnold Menezes
Journal:  J Craniovertebr Junction Spine       Date:  2014-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.